|
1
|
Kopan R and Ilagan MX: The canonical notch
signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roy M, Pear WS and Aster JC: The
multifaceted role of Notch in cancer. Curr Opin Genet Dev.
17:52–59. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katoh M: Dysregulation of stem cell
signaling network due to germline mutation, SNP, Helicobacter
pylori infection, epigenetic change and genetic alteration in
gastric cancer. Cancer Biol Ther. 6:832–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Katoh M and Katoh M: Notch signaling in
gastrointestinal tract. Int J Oncol. 30:247–251. 2007.PubMed/NCBI
|
|
6
|
Dontu G, Jackson KW, McNicholas E,
Kawamura MJ, Abdallah WM and Wicha MS: Role of Notch signaling in
cell-fate determination of human mammary stem/progenitor cells.
Breast Cancer Res. 6:R605–R615. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Liu W, Tang D, Xiao H, Wu Z, Chen C,
Yao X, Liu F and Li G: Prognostic values of four Notch receptor
mRNA expression in gastric cancer. Sci Rep. 6:280442016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Wang X, Xu J and Sun Y: Notch1
activation is a poor prognostic factor in patients with gastric
cancer. Br J Cancer. 110:2283–2290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo DH, Zhou Q, Hu SK, Xia YQ, Xu CC, Lin
TS, Pan YT, Wu JS and Jin R: Differential expression of Notch1
intracellular domain and p21 proteins and their clinical
significance in gastric cancer. Oncol Lett. 7:471–478. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Konishi H, Asano N, Imatani A, Kimura O,
Kondo Y, Jin X, Kanno T, Hatta W, Ara N, Asanuma K, et al: Notch1
directly induced CD133 expression in human diffuse type gastric
cancers. Oncotarget. 7:56598–56607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhen-Jun S1, Yuan-Yuan Z, Ying-Ying F,
Shao-Ju J, Jiao Y, Xiao-Wei Z, Jian C, Yao X and Li-Ming Z: β,
β-Dimethylacrylshikonin exerts antitumor activity via Notch-1
signaling pathway in vitro and in vivo. Biochem Pharmacol.
84:507–512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L, Wang WY and Cao LP: SIRT3 inhibits
cell proliferation in human gastric cancer through down-regulation
of Notch-1. Int J Clin Exp Med. 8:5263–5271. 2015.PubMed/NCBI
|
|
14
|
Li LC, Wang DL, Wu YZ, Nian WQ, Wu ZJ, Li
Y, Ma HW and Shao JH: Gastric tumor-initiating CD44+ cells and
epithelial-mesenchymal transition are inhibited by gamma-secretase
inhibitor DAPT. Oncol Lett. 10:3293–3299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan C, Yu J, Kang W, Liu Y, Ma Z and Zhou
L: miR-935 suppresses gastric signet ring cell carcinoma
tumorigenesis by targeting Notch1 expression. Biochem Biophys Res
Commun. 470:68–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji Q, Hao X, Meng Y, Zhang M, Desano J,
Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits
human p53-mutant gastric cancer tumorspheres. BMC Cancer.
8:2662008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hsu KW, Fang WL, Huang KH, Huang TT, Lee
HC, Hsieh RH, Chi CW and Yeh TS: Notch1 pathway-mediated
microRNA-151-5p promotes gastric cancer progression. Oncotarget.
7:38036–38051. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Gao X, Liu J, Kong QY, Wang XW,
Chen XY, Wang Q, Cheng YF, Qu XX and Li H: Differential Notch1 and
Notch2 expression and frequent activation of Notch signaling in
gastric cancers. Arch Pathol Lab Med. 135:451–458. 2011.PubMed/NCBI
|
|
20
|
Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang
MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH and Yeh TS:
Notch2-induced COX-2 expression enhancing gastric cancer
progression. Mol Carcinog. 51:939–951. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang H, An HJ, Song JY, Kim TH, Heo JH,
Ahn DH and Kim G: Notch3 and Jagged2 contribute to gastric cancer
development and to glandular differentiation associated with MUC2
and MUC5AC expression. Histopathology. 61:576–586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian C, Liu F, Ye B, Zhang X, Liang Y and
Yao J: Notch4 promotes gastric cancer growth through activation of
Wnt1/β-catenin signaling. Mol Cell Biochem. 401:165–174. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Williams CS, Tsujii M, Reese J, Dey SK and
DuBois RN: Host cyclooxygenase-2 modulates carcinoma growth. J Clin
Invest. 105:1589–1594. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gupta S, Srivastava M, Ahmad N, Bostwick
DG and Mukhtar H: Over-expression of cyclooxygenase-2 in human
prostate adenocarcinoma. Prostate. 42:73–78. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cervello M, Bachvarov D, Cusimano A,
Sardina F, Azzolina A, Lampiasi N, Giannitrapani L, McCubrey JA and
Montalto G: COX-2-dependent and COX-2-independent mode of action of
celecoxib in human liver cancer cells. OMICS. 15:383–392. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC,
Li AF, Wang AM, Kuo ML and Chi CW: The activated Notch1 signal
pathway is associated with gastric cancer progression through
cyclooxygenase-2. Cancer Res. 69:5039–5048. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: World Health Organization and International Agency for
Research on Cancer: WHO Classification of Tumours of the Digestive
System. IARC Press; Lyon: 2010
|
|
28
|
Yang W, Soares J, Greninger P, Edelman EJ,
Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et
al: Genomics of drug sensitivity in cancer (GDSC): A resource for
therapeutic biomarker discovery in cancer cells. Nucleic Acids Res.
41:D955–D961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tu LC, Chou CK, Chen CY, Chang YT, Shen YC
and Yeh SF: Characterization of the cytotoxic mechanism of
Mana-Hox, an analog of manzamine alkaloids. Biochim Biophys Acta.
1672:148–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin YH, Kim H, Oh M, Ki H and Kim K:
Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta.
Mol Cells. 27:15–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Freire AG, Waghray A, Soares-da-Silva F,
Resende TP, Lee DF, Pereira CF, Nascimento DS, Lemischka IR and
Pinto-do-Ó P: Transient HES5 activity instructs mesodermal cells
toward a cardiac fate. Stem Cell Reports. 9:136–148. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kitagawa M, Hojo M, Imayoshi I, Goto M,
Ando M, Ohtsuka T, Kageyama R and Miyamoto S: Hes1 and Hes5
regulate vascular remodeling and arterial specification of
endothelial cells in brain vascular development. Mech Dev.
130:458–466. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Somi MH, Ghojazadeh M, Bagheri M and
Tahamtani T: Clinicopathological factors and gastric cancer
prognosis in the Iranian population: A meta-analysis. Asian Pac J
Cancer Prev. 16:853–857. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jung DH, Bae YS, Yoon SO, Lee YC and Kim
H, Noh SH, Park H, Choi SH, Kim JH and Kim H: Poorly differentiated
carcinoma component in submucosal layer should be considered as an
additional criterion for curative endoscopic resection of early
gastric cancer. Ann Surg Oncol. 22 Suppl 3:S772–S777. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Turkoz FP, Solak M, Kilickap S, Ulas A,
Esbah O, Oksuzoglu B and Yalcin S: Bone metastasis from gastric
cancer: The incidence, clinicopathological features and influence
on survival. J Gastric Cancer. 14:164–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu C, Wang ZN, Sun Z and Xu HM:
Clinicopathologic features and prognosis of gastric cancer in young
adults. Zhonghua Wai Ke Za Zhi. 46:1468–1471. 2008.(In Chinese).
PubMed/NCBI
|
|
38
|
Zu H, Wang H, Li C and Xue Y:
Clinicopathologic characteristics and prognostic value of various
histological types in advanced gastric cancer. Int J Clin Exp
Pathol. 7:5692–5700. 2014.PubMed/NCBI
|
|
39
|
Yoshinori N and Hideyuki O: New insight
into cancer therapeutics: Induction of differentiation by
regulating the Musashi/Numb/Notch pathway. Cell Res. 20:1083–1085.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng P, Kumar V, Liu H, Youn JI, Fishman
M, Sherman S and Gabrilovich D: Effects of notch signaling on
regulation of myeloid cell differentiation in cancer. Cancer Res.
74:141–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sikandar SS, Pate KT, Anderson S, Dizon D,
Edwards RA, Waterman ML and Lipkin SM: NOTCH signaling is required
for formation and self-renewal of tumor-initiating cells and for
repression of secretory cell differentiation in colon cancer.
Cancer Res. 70:1469–1478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Danza G, Di Serio C, Rosati F, Lonetto G,
Sturli N, Kacer D, Pennella A, Ventimiglia G, Barucci R, Piscazzi
A, et al: Notch signaling modulates hypoxia-induced neuroendocrine
differentiation of human prostate cancer cells. Mol Cancer Res.
10:230–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sjölund J, Manetopoulos C, Stockhausen MT
and Axelson H: The Notch pathway in cancer: Differentiation gone
awry. Eur J Cancer. 41:2620–2629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li LC, Peng Y, Liu YM, Wang LL and Wu XL:
Gastric cancer cell growth and epithelial-mesenchymal transition
are inhibited by γ-secretase inhibitor DAPT. Oncol Lett.
7:2160–2164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Y, Ye J, Chen Z, Wen J, Li F, Su P, Lin
Y, Hu B, Wu D, Ning L, et al: Annonaceous acetogenins mediated
up-regulation of Notch2 exerts growth inhibition in human gastric
cancer cells in vitro. Oncotarget. 8:21140–21152. 2017.PubMed/NCBI
|
|
46
|
Davide T and Livio T: Oncogene addiction
as a foundational rationale for targeted anti-cancer therapy:
Promises and perils. EMBO Mol Med. 3:623–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wong H and Yau T: Targeted therapy in the
management of advanced gastric cancer: Are we making progress in
the era of personalized medicine? Oncologist. 17:346–358. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang J, Zhang L, Su X, Li M, Xie L,
Malchers F, Fan S, Yin X, Xu Y, Liu K, et al: Translating the
therapeutic potential of AZD4547 in FGFR1-amplified non-small cell
lung cancer through the use of patient-derived tumor xenograft
models. Clin Cancer Res. 18:6658–6667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Guo LY, Li YM, Qiao L, Liu T, Du YY, Zhang
JQ, He WT, Zhao YX and He DQ: Notch2 regulates matrix
metallopeptidase 9 via PI3K/AKT signaling in human gastric
carcinoma cell MKN-45. World J Gastroenterol. 18:7262–7270. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou W, Fu XQ, Zhang LL, Zhang J, Huang X,
Lu XH, Shen L, Liu BN, Liu J, Luo HS, et al: The
AKT1/NF-kappaB/Notch1/PTEN axis has an important role in
chemoresistance of gastric cancer cells. Cell Death Dis.
4:e8472013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang Y, Lim SK, Choong LY, Lee H, Chen Y,
Chong PK, Ashktorab H, Wang TT, Salto-Tellez M, Yeoh KG and Lim YP:
Cathepsin S mediates gastric cancer cell migration and invasion via
a putative network of metastasis-associated proteins. J Proteome
Res. 9:4767–4778. 2010. View Article : Google Scholar : PubMed/NCBI
|
